Back

Non-recommended dosing of direct oral anticoagulants in acute pulmonary embolism is related to an increased rate of adverse events at 6 months: results of a prospective regional multicenter registry

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Acute and chronic pulmonary hypertension : treatment Treatment ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Guillaume Serzian

Regional University Hospital Jean Minjoz, Besancon (France)

9 More presentations in this session

Presentation thumbnail
Efficacy and safety of direct oral anticoagulants in intermediate-high risk pulmonary embolism: results from a multidisciplinary multicenter prospective registry
Doctor R. Chopard (Besancon, FR)
Abstract
Presentation thumbnail
Extracorporeal membrane oxygenation in patients with pulmonary embolism
Professor N. Meneveau (Besancon, FR)
Abstract Slides
Presentation thumbnail
Transthoracic pulmonary artery denervation attenuates the progression of pulmonary arterial hypertension in a rat model
Doctor Y. Huang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Comparison of cardiac output measurement methods for mortality prediction in pulmonary hypertension
Doctor E. Simsek (Izmir, TR)
Abstract Slides
Presentation thumbnail
Effect of pulmonary arterial hypertension specific therapy in the four clinical subgroups of patients with pulmonary arterial hypertension associated with congenital heart disease
Doctor D. Guarino (Bologna, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Acute and chronic pulmonary hypertension : treatment

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources